Aller au contenu principal
Profil bibliographique

Miodrag Vučić

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

38Publications signalées
81Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Platelet Disorders and TreatmentsChronic Myeloid Leukemia TreatmentsBlood transfusion and managementAntiplatelet Therapy and Cardiovascular DiseasesHemophilia Treatment and Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets

Shih-Chun A. Chu, Yi Hsiao, Chenwei Wang, Jennifer E. Kyle et autres

Acute myeloid leukemia (AML) is a genetically and phenotypically heterogeneous hematological malignancy. Here, to better define this clinically taxing and translationally challenging malignancy, we applied a multiomics approach, consisting of 13 modalities to analyze 173 treatment-naive individuals with AML. By integrating these …

us, my, pl (code pays fourni par la source)

3 citations Nature Cancer
Accès ouvert 2025 article OpenAlex

CHARACTERISTICS AND MANAGEMENT OF PATIENTS WITH MULTIPLE MYELOMA: A SINGLE-CENTER EXPERIENCE

Ina Konstantinović, Irena Ćojbašić, Miodrag Vučić

Multiple myeloma is the second most common hematological malignancy in which pathological plasma cells secrete monoclonal proteins, ultimately leading to end-organ damage. Albumin, β2-microglobulin, and LDH are considered highly relevant biomarkers for the diagnosis and prognosis of this disease. There are different …

rs (code pays fourni par la source)

0 citations AFMN Biomedicine
Accès ouvert 2025 article OpenAlex

ASSESSMENT OF TREATMENT OUTCOMES IN MULTIPLE MYELOMA ACCORDING TO PROGNOSTIC FACTORS AND THERAPEUTIC APPROACH

Dragana Drašković, Goran Marjanović, Miodrag Vučić, Irena Ćojbašić

Multiple myeloma is a malignant plasma cell disorder characterized by clonal proliferation of abnormal plasma cells. Global five-year survival rates range from 60% to 70%, largely due to novel therapeutic strategies. In our country, conventional therapies remain standard, with monoclonal antibodies recently …

rs (code pays fourni par la source)

0 citations AFMN Biomedicine
Accès ouvert 2025 article OpenAlex

ENZYME REPLACEMENT THERAPY IN PATIENTS WITH TYPE 1 GAUCHER DISEASE: A SINGLE-CENTER EXPERIENCE

Ivana Golubović, Miodrag Vučić, Irena Ćojbašić, Milan Lazarević et autres

Gaucher disease (GD) is a liposomal storage disorder inherited in an autosomal recessive pattern.The underlying cause of the disease is a mutation within the gene that encodes the enzyme glucocerebrosidase.Accumulation of glucocerebrosidase in macrophages in the liver, spleen, bone marrow, rarely in …

0 citations Acta Medica Medianae
Accès ouvert 2024 article OpenAlex

THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: OUR EXPERIENCE

Ivana Golubović, Miodrag Vučić, Irena Ćojbašić, Ivan Tijanić et autres

The primary immuna thrombocytopenia (ITP) is an acquired autoimmune disease characterized by isolated thrombocytopenia PLT < 100 x 10 9 /L, and the absence of all conditions and diseases that can result in thrombocytopenia.The first-line therapy in ITP involves the use of …

rs (code pays fourni par la source)

0 citations Acta Medica Medianae
Accès ouvert 2024 article OpenAlex

Indicators of stress hematopoiesis in the blood predict COVID-19 progression in patients over 65 years old

Miodrag Vučić, Jelena Milenković, Boris Djindjić, Vladana Stojiljković et autres

OBJECTIVES: Advanced age is a well-established risk factor for severe coronavirus disease 2019 (COVID-19). Exacerbated inflammation affects multiple organs, among which hematopoiesis responds by increased output of various cells. We aimed to determine the association between COVID-19 progression and large immature cell …

rs (code pays fourni par la source)

0 citations Hematology
Accès ouvert 2024 article OpenAlex

Hodgkin transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma

Miodrag Vučić, Bozidar Lilic, Slavica Stojnev

Introduction. In rare cases, chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma may transform into Hodgkin lymphoma, with about a hundred cases reported in the literature so far. We present a case of the Hodgkin variant of Richter transformation. Case report. After a one-year …

rs (code pays fourni par la source)

0 citations Vojnosanitetski pregled
Accès ouvert 2023 article OpenAlex

BLEEDING ASSESSMENT TOOLS

Miodrag Vučić, Sanja Veličković, Božidar Lilić

Bleeding Assessment Tools (BATs) are bleeding scoring systems used for screening and quantitative assessment of mild bleeding disorders.They consist of a standardized questionnaire and a scoring system that is used for the summation of the final score.In this review article, we have …

rs (code pays fourni par la source)

1 citation Acta Medica Medianae
Accès ouvert 2023 article OpenAlex

Non-factor replacement therapy: A new chapter in hemophilia a prophylaxis

Miodrag Vučić, Božidar Lilić, Danijela Jovančić-Petković, Jelena Vučić

Hemophilia A is an antihemophilic factor deficiency which requires life-long treatment. The aim of this analysis was to present the effects of prophylactic non-factor replacement therapy in ten patients with hemophilia A. This retrospective analysis was conducted on ten male patients (4 …

rs (code pays fourni par la source)

0 citations AFMN Biomedicine
Accès ouvert 2022 article OpenAlex

STEPS IN DIAGNOSIS OF CHRONIC IDIOPATHIC NEUTROPENIA: IS IT THE TIME FOR SERBIAN PATIENT REGISTRY?

Sanja Veličković, Miodrag Vučić, NIKOLA Z. STEFANOVIĆ, Filip Veličković et autres

Chronic neutropenia (CN) corresponds with absolute count of neutrophils below 1.8 × 10 9 /L in last three months.Besides, neutropenia that persists more than three months and in absence of underlying diseases, chemical components, irradiation, use of particular drugs, inflammation, is defined …

rs, gr (code pays fourni par la source)

0 citations Acta Medica Medianae
Accès ouvert 2022 article OpenAlex

Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents – a retrospective analysis

Irena Ćojbašić, Miodrag Vučić, Ivan Tijanić, Žarko Ćojbašić

Abstract BACKGROUND: In this era of target therapies, novel data on the correlation between response endpoints and survival outcomes in multiple myeloma have arisen. OBJECTIVE: To determine the impact of quality of response on clinical outcomes, using first-line treatment, and identify risk …

rs (code pays fourni par la source)

1 citation LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.